These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 2996919)

  • 21. Aging, menopause, and free radicals.
    Schwenke DC
    Semin Reprod Endocrinol; 1998; 16(4):281-308. PubMed ID: 10101810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.
    Wilson PW; Garrison RJ; Castelli WP
    N Engl J Med; 1985 Oct; 313(17):1038-43. PubMed ID: 2995808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of estrogens and estrogen-induced effects on nonreproductive organs and systems.
    Gorrill MJ; Marshall JR
    J Reprod Med; 1986 Sep; 31(9 Suppl):842-7. PubMed ID: 3772905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can menopause be considered an independent risk factor for cardiovascular disease?
    Mercuro G; Zoncu S; Cherchi A; Rosano GM
    Ital Heart J; 2001 Oct; 2(10):719-27. PubMed ID: 11721715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
    Ellis J
    Clin Ther; 1986; 8(6):607-18. PubMed ID: 3539347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotection by estrogens: mechanisms of action--the lipids.
    Samsioe G
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():43-9. PubMed ID: 8199640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.
    N Engl J Med; 1974 Jan; 290(1):15-9. PubMed ID: 4357161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of estradiol on blood lipids and lipoproteins in postmenopausal women.
    Fåhraeus L
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):18S-22S. PubMed ID: 3173937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
    Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J
    Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
    Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
    Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease.
    Knopp RH
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):23S-30S. PubMed ID: 3050656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The significance of ovarian and testicular steroids in lipid metabolism and atherogenesis].
    Marek J
    Vnitr Lek; 1992 Sep; 38(9):913-20. PubMed ID: 1481391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.